NorthStar Medical Radioisotopes and Convergent Therapeutics have announced an ex...
The Ministry of Health and Prevention in the UAE has granted approval for BioArc...
AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan), has received ...
Eli Lilly and Company has opened the Lilly Seaport Innovation Center (LSC), an R...
The court rebuffed claims by Novartis that it would experience “irreparable harm...
IGNYTE-3 is a Phase III trial investigating Replimune’s flagship oncolytic treat...
Kezar plans to focus all efforts on zetomipzomib, which is being evaluated in tw...
Africa CDC’s director general Dr. Jean Kaseya stated the number of rising mpox c...
Blue Earth Therapeutics' collaboration with Seibersdorf Labor will include the p...
As antibody drug conjugate (ADC)-centred deals dominate the oncology space, biot...
Sable Therapeutics has signed an agreement with Columbia University to develop n...
The US FDA has approved ARS Pharmaceuticals' neffy, an anyphylaxis nasal spray 2...
As Regeneron and Bayer fend off competition for Eylea copycats in the courts, Sa...
Abrysvo was found to be safe in immunocompromised adults at risk for developing ...
Seizures in a patient with KIF1A-associated neurological disorder (KAND) fell fr...
Leap Consulting Group has launched a practice aimed at guiding Clinical Laborato...
